Language repetition and short-term memory: an integrative framework.
Steve Majerus
https://pubmed.ncbi.nlm.nih.gov/23874280/Actively Recruiting
Led by Centre Psychothérapique de Nancy · Updated on 2026-03-27
90
Participants Needed
1
Research Sites
18 weeks
Total Duration
Researchers are studying language disorders in people with psychosis, including those at risk, experiencing a first episode, or diagnosed with schizophrenia. The study aims to understand how language difficulties affect communication and relate to thought disorders and neuropsychological symptoms. It also explores interactions between working memory and syntax abilities in these patients. The research compares patients language skills with those of healthy volunteers without mental or language disorders. Participants are divided into groups those with early psychotic symptoms ARMS and FEP, patients with schizophrenia, and healthy controls. Each group undergoes language assessments evaluating various language domains such as phonology, semantics, and pragmatics. Schizophrenia patients additionally complete the TLC scale, while all participants complete the Cannabis Abuse Screening Test CAST. Healthy controls also complete a psychiatric screening using the MINI. During the study, participants undergo comprehensive evaluations including language tests, psychiatric interviews, and neuropsychological assessments. Researchers measure language assessment performance, severity of speech disorganization, thought disorder symptoms, and working memory capacities. Data from medical records are analyzed for associations between language skills and psychiatric symptoms. The study enrollment includes participants aged 16 to 55 years and involves one day of assessments.
CONDITIONS
Study of Language Disorders and Interactions Between Mnesic Capabilities and Semantic Competencies in Patients With Psychosis
A
Anaëlle PAJAUD
N
Naoual MELLOUKI, PhD
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Centre Psychothérapique de Nancy
Lead Sponsor
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - 1 day
Participants undergo a battery of standardized language and psychiatric assessments including language assessment, Cannabis Abuse Screening Test (CAST), and other psychiatric scales depending on group assignment.
1 visit (in-person)
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NON_RANDOMIZED
Model
PARALLEL
Primary Purpose
DIAGNOSTIC
Number of Arms
3
Have more questions? Get in touch with our team for quick support
Steve Majerus
https://pubmed.ncbi.nlm.nih.gov/23874280/Centre Psychothérapique de Nancy
Lead Sponsor